Javier Afeltra

796 total citations
20 papers, 483 citations indexed

About

Javier Afeltra is a scholar working on Infectious Diseases, Epidemiology and Organic Chemistry. According to data from OpenAlex, Javier Afeltra has authored 20 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 13 papers in Epidemiology and 6 papers in Organic Chemistry. Recurrent topics in Javier Afeltra's work include Antifungal resistance and susceptibility (15 papers), Fungal Infections and Studies (9 papers) and Infectious Diseases and Mycology (3 papers). Javier Afeltra is often cited by papers focused on Antifungal resistance and susceptibility (15 papers), Fungal Infections and Studies (9 papers) and Infectious Diseases and Mycology (3 papers). Javier Afeltra collaborates with scholars based in Argentina, Netherlands and United States. Javier Afeltra's co-authors include Paul E. Verweij, Roxana G. Vitale, Éric Dannaoui, Jacques F. Meis, Johan W. Mouton, Albertina G. Moglioni, Graciela Y. Moltrasio, Juan L. Rodrı́guez-Tudela, Guillermo García‐Effrón and Catiana Dudiuk and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and AIDS.

In The Last Decade

Javier Afeltra

20 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Afeltra Argentina 12 334 264 106 86 53 20 483
D. T. A. Te Dorsthorst Netherlands 11 368 1.1× 259 1.0× 65 0.6× 44 0.5× 70 1.3× 14 471
Laurence F. Mirels United States 10 539 1.6× 456 1.7× 131 1.2× 49 0.6× 61 1.2× 11 734
Antonia Geber United States 8 364 1.1× 239 0.9× 167 1.6× 38 0.4× 94 1.8× 10 562
Marcos Olivo United States 16 590 1.8× 495 1.9× 53 0.5× 51 0.6× 77 1.5× 19 624
Derek Law United States 13 619 1.9× 497 1.9× 98 0.9× 88 1.0× 66 1.2× 17 716
Hoja Patterson United States 11 388 1.2× 350 1.3× 47 0.4× 42 0.5× 42 0.8× 21 477
Francisca Jakelyne de Farias Marques Brazil 12 227 0.7× 235 0.9× 91 0.9× 42 0.5× 25 0.5× 16 391
Chiatogu Onyewu United States 7 392 1.2× 246 0.9× 199 1.9× 59 0.7× 82 1.5× 7 530
Shirin Farahyar Iran 14 212 0.6× 192 0.7× 96 0.9× 89 1.0× 46 0.9× 37 524
Rodrigo Rollin‐Pinheiro Brazil 11 236 0.7× 157 0.6× 120 1.1× 34 0.4× 42 0.8× 27 376

Countries citing papers authored by Javier Afeltra

Since Specialization
Citations

This map shows the geographic impact of Javier Afeltra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Afeltra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Afeltra more than expected).

Fields of papers citing papers by Javier Afeltra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Afeltra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Afeltra. The network helps show where Javier Afeltra may publish in the future.

Co-authorship network of co-authors of Javier Afeltra

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Afeltra. A scholar is included among the top collaborators of Javier Afeltra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Afeltra. Javier Afeltra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vitale, Roxana G., et al.. (2022). An overview of COVID-19 related to fungal infections: what do we know after the first year of pandemic?. Brazilian Journal of Microbiology. 53(2). 759–775. 5 indexed citations
2.
3.
Hoog, Sybren de, et al.. (2017). Differential distribution patterns of Fonsecaea agents of chromoblastomycosis, exemplified by the first case due to F. monophora from Argentina. Medical Mycology Case Reports. 20. 35–38. 5 indexed citations
4.
Martini, M. Florencia, Roxana G. Vitale, Lucas Fabián, et al.. (2017). N-haloacetyl phenothiazines and derivatives: Preparation, characterization and structure-activity relationship for antifungal activity. Arabian Journal of Chemistry. 12(1). 21–32. 10 indexed citations
5.
Radisic, Marcelo, et al.. (2016). Acute pulmonary involvement by paracoccidiodomycosis disease immediately after kidney transplantation: Case report and literature review. Transplant Infectious Disease. 19(2). 9 indexed citations
6.
Dudiuk, Catiana, Soledad Gamarra, Cristina Jiménez‐Ortigosa, et al.. (2014). Set of Classical PCRs for Detection of Mutations in Candida glabrata FKS Genes Linked with Echinocandin Resistance. Journal of Clinical Microbiology. 52(7). 2609–2614. 45 indexed citations
7.
8.
Córdoba, Susana, Javier Afeltra, & Roxana G. Vitale. (2011). Evaluation of the in vitro activity of amphotericin B by time–kill curve methodology against large and small capsulate C. neoformans isolates. Diagnostic Microbiology and Infectious Disease. 71(3). 260–262. 13 indexed citations
9.
Vitale, Roxana G., et al.. (2011). Influence of capsule size on the in vitro activity of antifungal agents against clinical Cryptococcus neoformans var. grubii strains. Journal of Medical Microbiology. 61(3). 384–388. 17 indexed citations
10.
Vitale, Roxana G., et al.. (2010). Synthesis and antifungal activity of some substituted phenothiazines and related compounds. European Journal of Medicinal Chemistry. 46(1). 101–105. 38 indexed citations
11.
Vitale, Roxana G., Javier Afeltra, Jacques F. Meis, & Paul E. Verweij. (2007). Activity and post antifungal effect of chlorpromazine and trifluopherazine against Aspergillus, Scedosporium and zygomycetes. Mycoses. 50(4). 270–276. 23 indexed citations
12.
Vitale, Roxana G., Javier Afeltra, & Éric Dannaoui. (2005). Antifungal Combinations. Humana Press eBooks. 118. 143–152. 58 indexed citations
13.
Afeltra, Javier, Roxana G. Vitale, Johan W. Mouton, & Paul E. Verweij. (2004). Potent Synergistic In Vitro Interaction between Nonantimicrobial Membrane-Active Compounds and Itraconazole against Clinical Isolates of Aspergillus fumigatus Resistant to Itraconazole. Antimicrobial Agents and Chemotherapy. 48(4). 1335–1343. 51 indexed citations
14.
Afeltra, Javier & Paul E. Verweij. (2003). Antifungal Activity of Nonantifungal Drugs. European Journal of Clinical Microbiology & Infectious Diseases. 22(7). 397–407. 50 indexed citations
15.
Afeltra, Javier, Jacques F. Meis, Roxana G. Vitale, Johan W. Mouton, & Paul E. Verweij. (2002). In Vitro Activities of Pentamidine, Pyrimethamine, Trimethoprim, and Sulfonamides against Aspergillus Species. Antimicrobial Agents and Chemotherapy. 46(6). 2029–2031. 21 indexed citations
16.
Dannaoui, Éric, Javier Afeltra, Jacques F. Meis, & Paul E. Verweij. (2002). In Vitro Susceptibilities of Zygomycetes to Combinations of Antimicrobial Agents. Antimicrobial Agents and Chemotherapy. 46(8). 2708–2711. 58 indexed citations
17.
Afeltra, Javier, Éric Dannaoui, Jacques F. Meis, Juan L. Rodrı́guez-Tudela, & Paul E. Verweij. (2002). In Vitro Synergistic Interaction between Amphotericin B and Pentamidine against Scedosporium prolificans. Antimicrobial Agents and Chemotherapy. 46(10). 3323–3326. 35 indexed citations
18.
Vitale, Roxana G., Johan W. Mouton, Javier Afeltra, Jacques F. Meis, & Paul E. Verweij. (2002). Method for Measuring Postantifungal Effect inAspergillusSpecies. Antimicrobial Agents and Chemotherapy. 46(6). 1960–1965. 24 indexed citations
19.
Afeltra, Javier, Jacques F. Meis, Johan W. Mouton, & Paul E. Verweij. (2001). Prevention of invasive aspergillosis in AIDS by sulfamethoxazole. AIDS. 15(8). 1067–1068. 7 indexed citations
20.
Afeltra, Javier, et al.. (1995). Interferon gamma increases survival in urine experimental cryptococcosis. Revista do Instituto de Medicina Tropical de São Paulo. 37(5). 391–396. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. T. A. Te Dorsthorst Breakdown of academic impact, for papers by Laurence F. Mirels Breakdown of academic impact, for papers by Antonia Geber Breakdown of academic impact, for papers by Marcos Olivo Breakdown of academic impact, for papers by Derek Law Breakdown of academic impact, for papers by Hoja Patterson Breakdown of academic impact, for papers by Francisca Jakelyne de Farias Marques Breakdown of academic impact, for papers by Chiatogu Onyewu Breakdown of academic impact, for papers by Shirin Farahyar Breakdown of academic impact, for papers by Rodrigo Rollin‐Pinheiro
Rankless by CCL
2026